Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
FIGS, Inc.
FIGS
NYSE·Consumer Cyclical·Apparel - Manufacturers·Mkt cap $1.7B
$9.99
▼ -0.60%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$5.66 - $17.48
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 70.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Direct-to-consumer digital platform eliminates middlemen and reduces costs
- Strong brand loyalty among healthcare professionals with community engagement
- Vertical integration and supply chain control enabling quality and margin optimization
- Premium positioning with affordable pricing in underserved medical apparel market
Bear Case
2 risks
- Average volatility.
- High premium - requires strong execution
Growth
Stable outlook
Expansion of product categories beyond scrubs into lifestyle and activewear
Value
High premium - requires strong execution
Momentum
Falling
-31.4% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying FIGS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of $0.03 vs $0.01 consensus (+200.0% surprise). Revenue of $159.9M vs $153.1M expected (+4.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+200.0%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
+5%
+5%
+6%
+8%
+33%
+28%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$144.2M
$140.2M
$151.8M
$124.9M
$152.6M
$151.7M
$201.9M
$159.9M
Margins · last 8Q
Gross
—
Operating
—
Profit
3.9%
Wall Street consensus
6 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
33%
Sell
17%
Median Price Target
$19.00
▲ +90.2% vs $9.99
Latest: KeyBanc · Jun 23, 2026
1 analyst covering